|Bid||160.73 x 800|
|Ask||219.99 x 800|
|Day's Range||160.38 - 164.39|
|52 Week Range||160.38 - 236.81|
|Beta (5Y Monthly)||0.35|
|PE Ratio (TTM)||43.12|
|Earnings Date||Nov 02, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||239.18|
LHC Group (LHCG) continues to benefit from strategic deals and broad array of services.
How are we going to find a way forward in today’s market environment? The general trend is upwards – the S&P 500 has gained 20% so far this year, and the NASDAQ is close behind at 19% – but market strategists at Goldman Sachs are predicting a pull back before the end of the year, and have scaled back their growth forecast for the S&P to from 6.2% to 5.7%. August’s weak jobs report and rising inflation prompted their shift. Looking at the headwinds, Goldman’s Ronnie Walker says, “The Delta varian
LHC Group, Inc. (NASDAQ: LHCG) today announced agreements to purchase two providers – one home health and one hospice – in Virginia, complementing and expanding on its existing footprint of providers in the state.